Arvind Mishra,
Joint President,
Cadila Pharmaceuticals Ltd
Dr Arvind Kumar Mishra, presently Strategic Business Unit Head , Cadila Biologicals and Joint President – Corporate QA/QC and RA at Cadila Pharmaceuticals Limited, Ahmedabad, Gujarat, India has more than 25 years of rich experience in the field of Global Quality Assurance , GMP compliance and National and Interationational Regulatory Affairs .
Dr Arvind Mishra has obtained his Masters degree in Analytical Chemistry from Banaras Hindu University (popularly known as BHU) in 1979 and a Doctorate in Science (Pharmaceutical Drug Analysis) in 1984. He has several research publications and review articles published in various National and International journals of repute. Dr Mishra was teaching to M .Tech (Biochemical Engineering students) at Institute of Technology, BHU for about 4 years before moving to pharmaceutical industry.
Dr Arvind Mishra has started his career in pharmaceutical industry more than 2 decades ago and worked with top 10 Indian companies in different capacities. Notable among them are Lupin, Strides Arcolab and Cadila Pharmaceuticals. Dr Mishra has travelled extensively to various countries , notable among them are US, UK, Australia , France, Germany , Japan, Venezuela, Romania, Brazil, Ukraine , Latvia , Trinidad and Tobago, South Africa, Nigeria, Uganda, Ethiopia, Bosnia, Syria, Singapore etc.
During this tenure of over 25 years in pharma industry, Dr Mishra has been closely interacting with Indian and various International Regulatory authorities around the world and helped companies increase presence and export business internationally by registering more than 1500 product dossiers including INDs ANDAs and several DMFs and COSs.
|
|